Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tobacco Induced Diseases
Published in: Tobacco Induced Diseases 1/2017

Open Access 01-12-2017 | Review

Experimental animal models for COPD: a methodological review

Authors: Vahideh Ghorani, Mohammad Hossein Boskabady, Mohammad Reza Khazdair, Majid Kianmeher

Published in: Tobacco Induced Diseases | Issue 1/2017

Login to get access

Abstract

Introduction

Chronic obstructive pulmonary disease (COPD) is a progressive disorder that makes the breathing difficult and is characterized by pathological conditions ranging from chronic inflammation to tissue proteolysis. With regard to ethical issues related to the studies on patients with COPD, the use of animal models of COPD is inevitable. Animal models improve our knowledge about the basic mechanisms underlying COPD physiology, pathophysiology and treatment. Although these models are only able to mimic some of the features of the disease, they are valuable for further investigation of mechanisms involved in human COPD.

Methods

We searched the literature available in Google Scholar, PubMed and ScienceDirect databases for English articles published until November 2015. For this purpose, we used 5 keywords for COPD, 3 for animal models, 4 for exposure methods, 3 for pathophysiological changes and 3 for biomarkers. One hundred and fifty-one studies were considered eligible for inclusion in this review.

Results

According to the reviewed articles, animal models of COPD are mainly induced in mice, guinea pigs and rats. In most of the studies, this model was induced by exposure to cigarette smoke (CS), intra-tracheal lipopolysaccharide (LPS) and intranasal elastase. There were variations in time course and dose of inducers used in different studies. The main measured parameters were lung pathological data and lung inflammation (both inflammatory cells and inflammatory mediators) in most of the studies and tracheal responsiveness (TR) in only few studies.

Conclusion

The present review provides various methods used for induction of animal models of COPD, different animals used (mainly mice, guinea pigs and rats) and measured parameters. The information provided in this review is valuable for choosing appropriate animal, method of induction and selecting parameters to be measured in studies concerning COPD.
Literature
1.
Beckett EL, Stevens RL, Jarnicki AG, Kim RY, Hanish I, Hansbro NG, et al. A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. J Allergy Clin Immunol. 2013;131(3):752–62. e757.PubMedPubMedCentralCrossRef
2.
Li Y, Li S-Y, Li J-S, Deng L, Tian Y-G, Jiang S-L, et al. A rat model for stable chronic obstructive pulmonary disease induced by cigarette smoke inhalation and repetitive bacterial infection. Biol Pharm Bull. 2012;35(10):1752–60.PubMedCrossRef
3.
Martorana PA, Cavarra E, Lucattelli M, Lungarella G. Models for COPD involving cigarette smoke. Drug Discov Today Dis Models. 2006;3(3):225–30.CrossRef
4.
Brusselle G, Bracke K, Maes T, D’hulst A, Moerloose K, Joos G, et al. Murine models of COPD. Pulm Pharmacol Ther. 2006;19(3):155–65.PubMedCrossRef
5.
Canning BJ, Wright JL. Animal models of asthma and chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2008;21(5):695.PubMedCrossRef
6.
Wright JL, Churg A. Animal models of COPD: barriers, successes, and challenges. Pulm Pharmacol Ther. 2008;21(5):696–8.PubMedCrossRef
7.
Eltom S, Stevenson C, Birrell MA. Cigarette smoke exposure as a model of inflammation associated with COPD. Curr Protoc Pharmacol. 2013:14.24. 11-14.24. 18.
8.
Vlahos R, Bozinovski S, Gualano R, Ernst M, Anderson G. Modelling COPD in mice. Pulm Pharmacol Ther. 2006;19(1):12–7.PubMedCrossRef
9.
Pera T. Inflammation and remodelling in experimental models of COPD. 2011.
10.
11.
12.
Bonfield TL. In vivo models of lung disease. in: Lung diseases - selected state of the art Reviews, InTech. 2012:407–28.
13.
Leberl M, Kratzer A, Taraseviciene-Stewart L. Tobacco smoke induced COPD/emphysema in the animal model—are we all on the same page? Front Physiol. 2013;4.
14.
O’byrne P, Postma D. The many faces of airway inflammation: asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(supplement_2):S1–S63.CrossRef
15.
Churg A, Tai H, Coulthard T, Wang R, Wright JL. Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am J Respir Crit Care Med. 2006;174(12):1327–34.PubMedCrossRef
16.
17.
Wright J, Postma D, Kerstjens H, Timens W, Whittaker P, Churg A. Airway remodeling in the smoke exposed guinea pig model. Inhal Toxicol. 2007;19(11):915–23.PubMedCrossRef
18.
Bracke K, D’hulst A, Maes T, Demedts I, Moerloose K, Kuziel W, et al. Cigarette smoke‐induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5‐deficient mice. Clin Exp Allergy. 2007;37(10):1467–79.PubMed
19.
Churg A, Cosio M, Wright JL. Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol. 2008;294(4):L612–31.PubMedCrossRef
20.
Wright JL, Churg A. Animal models of cigarette smoke-induced COPD. CHEST Journal. 2002;122(6_suppl):301S–6S.CrossRef
21.
Wright JL, Churg A. Animal models of cigarette smoke-induced chronic obstructive pulmonary disease. 2010.
22.
John G, Kohse K, Orasche J, Reda A, Schnelle-Kreis J, Zimmermann R, et al. The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models. Clin Sci. 2014;126(3):207–21.PubMedCrossRef
23.
Mallia P, Johnston SL. Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc. 2005;2(4):361–6.PubMedCrossRef
24.
March TH, Barr EB, Finch GL, Hahn FF, Hobbs CH, Ménache MG, et al. Cigarette smoke exposure produces more evidence of emphysema in B6C3F1 mice than in F344 rats. Toxicol Sci. 1999;51(2):289–99.PubMedCrossRef
25.
Adamson J, Haswell LE, Phillips G, Gaça MD. In vitro models of chronic obstructive pulmonary disease (COPD). In Bronchitis, ed. I Martin-Loeches. InTech. 2011;41–66.
26.
Hardaker L, Bahra P, de Billy BC, Freeman M, Kupfer N, Wyss D, et al. The ion channel transient receptor potential melastatin-2 does not play a role in inflammatory mouse models of chronic obstructive pulmonary diseases. Respir Res. 2012;13:30.PubMedPubMedCentralCrossRef
27.
Motz GT, Eppert BL, Wesselkamper SC, Flury JL, Borchers MT. Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2−/− mice. Am J Respir Crit Care Med. 2010;181(11):1223–33.PubMedPubMedCentralCrossRef
28.
Motz GT, Eppert BL, Wortham BW, Amos-Kroohs RM, Flury JL, Wesselkamper SC, et al. Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease. J Immunol. 2010;184(8):4460–9.PubMedCrossRef
29.
Cremona TP, Tschanz SA, von Garnier C, Benarafa C. SerpinB1 deficiency is not associated with increased susceptibility to pulmonary emphysema in mice. Am J Physiol Lung Cell Mol Physiol. 2013;305(12):L981–9.PubMedCrossRef
30.
Jobse BN, Rhem RG, Wang IQ, Counter WB, Stämpfli MR, Labiris NR. Detection of lung dysfunction using ventilation and perfusion SPECT in a mouse model of chronic cigarette smoke exposure. J Nucl Med. 2013;54(4):616–23.PubMedCrossRef
31.
Barrett EG, Wilder JA, March TH, Espindola T, Bice DE. Cigarette smoke-induced airway hyperresponsiveness is not dependent on elevated immunoglobulin and eosinophilic inflammation in a mouse model of allergic airway disease. Am J Respir Crit Care Med. 2002;165(10):1410–8.PubMedCrossRef
32.
Hansbro P, Beckett E, Stevens R, Jarnicki A, Wark P, Foster P. A short-term model of COPD identifies a role for mast cell tryptase. Eur Respir J. 2013;42 Suppl 57:664.
33.
34.
Tanabe N, Hoshino Y, Marumo S, Kiyokawa H, Sato S, Kinose D, et al. Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation. PLoS One. 2013;8(11), e79016.PubMedPubMedCentralCrossRef
35.
Stevenson CS, Docx C, Webster R, Battram C, Hynx D, Giddings J, et al. Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation. Am J Physiol Lung Cell Mol Physiol. 2007;293(5):L1183–93.PubMedCrossRef
36.
Kratzer A, Salys J, Nold-Petry C, Cool C, Zamora M, Bowler R, et al. Role of IL-18 in Second-Hand Smoke–Induced Emphysema. Am J Respir Cell Mol Biol. 2013;48(6):725–32.PubMedPubMedCentralCrossRef
37.
Kozma RH, Alves EM, Barbosa-de-Oliveira VA, Lopes FDTQ, Guardia RC, Buzo HV, et al. A new experimental model of cigarette smoke-induced emphysema in Wistar rats. J Bras Pneumol. 2014;40(1):46–4.PubMedCentralCrossRef
38.
Wang Y, Jiang X, Zhang L, Wang L, Li Z, Sun W. Simvastatin mitigates functional and structural impairment of lung and right ventricle in a rat model of cigarette smoke-induced COPD. Int J Clin Exp Pathol. 2014;7(12):8553–62.PubMedPubMedCentral
39.
Davis BB, Shen Y-H, Tancredi DJ, Flores V, Davis RP, Pinkerton KE. Leukocytes are recruited through the bronchial circulation to the lung in a spontaneously hypertensive rat model of COPD. PLoS One. 2012;7(3), e33304.PubMedPubMedCentralCrossRef
40.
Ramírez-Romero R, Nevárez-Garza AM, Rodríguez-Tovar LE, Wong-González A, Ledezma-Torres RA, Hernández-Vidal G. Histopathological Analogies in Chronic Pulmonary Lesions between Cattle and Humans: Basis for an Alternative Animal Model. Sci Word J. 2012;2012.
41.
Smith KR, Pinkerton KE, Watanabe T, Pedersen TL, Ma SJ, Hammock BD. Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc Natl Acad Sci USA. 2005;102(6):2186–91.PubMedPubMedCentralCrossRef
42.
Zheng H, Liu Y, Huang T, Fang Z, Li G, He S. Development and characterization of a rat model of chronic obstructive pulmonary disease (COPD) induced by sidestream cigarette smoke. Toxicol Lett. 2009;189(3):225–34.PubMedCrossRef
43.
Canning BJ. Modeling asthma and COPD in animals: a pointless exercise? Curr Opin Pharmacol. 2003;3(3):244–50.PubMedCrossRef
44.
Wright JL, Churg A. Cigarette Smoke Causes Physiologic and Morphologic Changes of Emphysema in the Guinea Pig1–3. Am Rev Respir Dis. 1990;142:1422–8.PubMedCrossRef
45.
Bourbon JR, Boucherat O, Boczkowski J, Crestani B, Delacourt C. Bronchopulmonary dysplasia and emphysema: in search of common therapeutic targets. Trends Mol Med. 2009;15(4):169–79.PubMedCrossRef
46.
47.
Ressmeyer A, Larsson A, Vollmer E, Dahlén S-E, Uhlig S, Martin C. Characterisation of guinea pig precision-cut lung slices: comparison with human tissues. Eur Respir J. 2006;28(3):603–11.PubMedCrossRef
48.
Muccitelli R, Tucker S, Hay D, Torphy T, Wasserman M. Is the guinea pig trachea a good in vitro model of human large and central airways? Comparison on leukotriene-, methacholine-, histamine-and antigen-induced contractions. J Pharmacol Exp Ther. 1987;243(2):467–73.PubMed
49.
Dalen H. An ultrastructural study of the tracheal epithelium of the guinea-pig with special reference to the ciliary structure. J Anat. 1983;136(Pt 1):47.PubMedPubMedCentral
50.
Boskabady MH, Gholami ML. Effect of the Zataria multiflora on systemic inflammation of experimental animals model of COPD. Biomed Res Int. 2014;2014.
51.
Ghorbani A, Feizpour A, Hashemzahi M, Gholami L, Hosseini M, Soukhtanloo M, et al. The effect of adipose derived stromal cells on oxidative stress level, lung emphysema and white blood cells of guinea pigs model of chronic obstructive pulmonary disease. Daru. 2014;22(1):22–6.CrossRef
52.
Feizpour A, Boskabady MH, Ghorbani A. Adipose-Derived Stromal Cell Therapy Affects Lung Inflammation and Tracheal Responsiveness in Guinea Pig Model of COPD. 2014.
53.
Mahtaj LG, Feizpour A, Kianmehr M, Soukhtanloo M, Boskabady MH. The effect of carvacrol on systemic inflammation in guinea pigs model of COPD induced by cigarette smoke exposure. Pharmacol Rep. 2015;67(1):140–5.PubMedCrossRef
54.
Boskabady MH, Kiani S, Khoei AR, Aslani MR. Tracheal Responsiveness to Histamine and Histamine (H1) Receptor Blockade by Chlorpheniramine in an Animal Model of COPD. Int J Pharmacol. 2005;1(4):350–6.CrossRef
55.
Boskabady MH, Kiani S, Aslani MR. Tracheal responsiveness to both isoprenaline and beta2‐adrenoreceptor blockade by propranolol in cigarette smoke exposed and sensitized guinea pigs. Respirology. 2006;11(5):572–8.PubMedCrossRef
56.
Boskabady MH, Jandaghi PP. Tracheal responsivness to methacholine and muscarinic receptor blockade by atropine in animal model of COPD. Pharmacologyonline. 2006;2:307–23.
57.
Boskabady M, Kiani S. The effect of exposure of guinea pig to cigarette smoke and their sensitization in tracheal responsiveness to histamine and histamine receptor (H 1) blockade by chlorpheniramine. Pathophysiology. 2007;14(2):97–4.PubMedCrossRef
58.
Keyhanmanesh R, Nazemiyeh H, Mazouchian H, Asl MMB, Shoar MK, Alipour MR, et al. Nigella sativa pretreatment in guinea pigs exposed to cigarette smoke modulates in vitro tracheal responsiveness. Iran Red Crescent Med J. 2014;16:e10421.
59.
60.
Auerbach O, Hammond EC, Kirman D, Garfinkel L. Emphysema produced in dogs by cigarette smoking. Jama. 1967;199(4):241–6.PubMedCrossRef
61.
Park SS, Kikkawa Y, Goldring IP, Daly MM, Zelefsky M, Shim C, et al. An Animal Model of Cigarette Smoking in Beagle Dogs: Correlative Evaluation of Effects on Pulmonary Function, Defense, and Morphology 1, 2. Am Rev Respir Dis. 1977;115(6):971–9.PubMed
62.
Frasca J, Auerbach O, Carter H, Parks V. Morphologic alterations induced by short-term cigarette smoking. Am J Pathol. 1983;111(1):11.PubMedPubMedCentral
63.
Plopper CG, Hyde DM. The non-human primate as a model for studying COPD and asthma. Pulm Pharmacol Ther. 2008;21(5):755–66.PubMedCrossRef
64.
65.
Wang L, Joad JP, Zhong C, Pinkerton KE. Effects of environmental tobacco smoke exposure on pulmonary immune response in infant monkeys. J Allergy Clin Immunol. 2008;122(2):400–6. e405.PubMedCrossRef
66.
Fehrenbach H. Animal models of pulmonary emphysema: a stereologist’s perspective. Eur Respir Rev. 2006;15(101):136–47.CrossRef
67.
Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. CHEST Journal. 1999;115(3):829–35.CrossRef
68.
Rylander R. Endotoxin and occupational airway disease. Curr Opin Allergy Clin Immunol. 2006;6(1):62–6.PubMedCrossRef
69.
Pera T, Zuidhof A, Valadas J, Smit M, Schoemaker RG, Gosens R, et al. Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. Eur Respir J. 2011;38(4):789–96.PubMedCrossRef
70.
Patel I, Seemungal T, Wilks M, Lloyd-Owen S, Donaldson G, Wedzicha J. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57(9):759–64.PubMedPubMedCentralCrossRef
71.
Spond J, Case N, Chapman R, Crawley Y, Egan R, Fine J, et al. Inhibition of experimental acute pulmonary inflammation by pirfenidone. Pulm Pharmacol Ther. 2003;16(4):207–14.PubMedCrossRef
72.
Toward TJ, Broadley KJ. Airway reactivity, inflammatory cell influx and nitric oxide in guinea‐pig airways after lipopolysaccharide inhalation. Br J Pharmacol. 2000;131(2):271–81.PubMedPubMedCentralCrossRef
73.
Vernooy JH, Dentener MA, Van Suylen RJ, Buurman WA, Wouters EF. Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells: no role for tumor necrosis factor-α and infiltrating neutrophils. Am J Respir Cell Mol Biol. 2001;24(5):569–76.PubMedCrossRef
74.
Brass DM, Hollingsworth JW, Cinque M, Li Z, Potts E, Toloza E, et al. Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. Am J Respir Cell Mol Biol. 2008;39(5):584–90.PubMedPubMedCentralCrossRef
75.
Toward TJ, Broadley KJ. Goblet cell hyperplasia, airway function, and leukocyte infiltration after chronic lipopolysaccharide exposure in conscious Guinea pigs: effects of rolipram and dexamethasone. J Pharmacol Exp Ther. 2002;302(2):814–21.PubMedCrossRef
76.
Vernooy JH, Dentener MA, Van Suylen RJ, Buurman WA, Wouters EF. Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol. 2002;26(1):152–9.PubMedCrossRef
77.
Sohn S-H, Jang H, Kim Y, Jang YP, Cho S-H, Jung H, et al. The effects of Gamijinhae-tang on elastase/lipopolysaccharide-induced lung inflammation in an animal model of acute lung injury. BMC Complement Altern Med. 2013;13(1):176.PubMedPubMedCentralCrossRef
78.
Sajjan U, Ganesan S, Comstock AT, Shim J, Wang Q, Nagarkar DR, et al. Elastase-and LPS-exposed mice display altered responses to rhinovirus infection. Am J Physiol Lung Cell Mol Physiol. 2009;297(5):L931–44.PubMedPubMedCentralCrossRef
79.
Al Faraj A, Shaik AS, Afzal S, Al Sayed B, Halwani R. MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles. Int J Nanomedicine. 2014;9:1491.PubMedPubMedCentralCrossRef
80.
Al Faraj A, Shaik AS, Pureza MA, Alnafea M, Halwani R. Preferential macrophage recruitment and polarization in LPS-induced animal model for COPD: noninvasive tracking using MRI. PLoS One. 2014;9(3), e90829.PubMedPubMedCentralCrossRef
81.
Hardaker E, Freeman M, Dale N, Bahra P, Raza F, Banner K, et al. Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung. Br J Pharmacol. 2010;160(8):1985–96.PubMedPubMedCentralCrossRef
82.
Baarsma HA, Bos S, Meurs H, Visser KH, Smit M, Schols A, et al. Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology. Respir Res. 2013;14(1):113.PubMedPubMedCentralCrossRef
83.
Janoff A. Elastases and Emphysema: Current Assessment of the Protease-Antiprotease Hypothesis 1–3. Am Rev Respir Dis. 1985;132(2):417–33.PubMed
84.
Antunes MA, Rocco PR. Elastase-induced pulmonary emphysema: insights from experimental models. An Acad Bras Cienc. 2011;83(4):1385–96.PubMedCrossRef
85.
Snider GL, Lucey EC, Stone PJ. Animal Models of Emphysema 1–3. Am Rev Respir Dis. 1986;133(1):149–69.PubMedCrossRef
86.
Emphysema GL. The first two centuries and beyond. A historial overview, with suggestions for future research: Part I. Am Rev Respir Dis. 1992;146:1334–44.CrossRef
87.
Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, et al. α-1 Antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol. 2006;169(4):1155–66.PubMedPubMedCentralCrossRef
88.
Karaaslan Ç, Hirakawa H, Yasumatsu R, Chang L-YL, Pierce RA, Crapo JD, et al. Elastase Inhibitory Activity of Airway &agr; 1-Antitrypsin Is Protected by Treatment With a Catalytic Antioxidant in a Baboon Model of Severe Bronchopulmonary Dysplasia. Pediatr Res. 2011;70(4):363–7.PubMedPubMedCentralCrossRef
89.
Chen JC, Brenner M, Kafie FE, Yoong B, Budd M, Gassel A, et al. An animal model for lung volume reduction therapy of pulmonary emphysema. J Invest Surg. 1998;11(2):129–37.PubMedCrossRef
90.
Ito S, Ingenito EP, Brewer KK, Black LD, Parameswaran H, Lutchen KR, et al. Mechanics, nonlinearity, and failure strength of lung tissue in a mouse model of emphysema: possible role of collagen remodeling. J Appl Physiol. 2005;98(2):503–11.PubMedCrossRef
91.
Rohrer J, Wuertz BR, Ondrey F. Cigarette smoke condensate induces nuclear factor kappa‐b activity and proangiogenic growth factors in aerodigestive cells. Laryngoscope. 2010;120(8):1609–13.PubMedCrossRef
92.
Rose JE, Behm FM, Murugesan T, McClernon FJ. Silver acetate interactions with nicotine and non-nicotine smoke components. Exp Clin Psychopharmacol. 2010;18(6):462.PubMedCrossRef
93.
Lieberman J. Elastase, collagenase, emphysema, and alpha1-antitrypsin deficiency. Chest. 1976;70:62–7.PubMedCrossRef
94.
Ishizawa K, Kubo H, Yamada M, Kobayashi S, Numasaki M, Ueda S, et al. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett. 2004;556(1):249–52.PubMedCrossRef
95.
Vidal D, Fortunato G, Klein W, Cortizo L, Vasconcelos J, Ribeiro-Dos-Santos R, et al. Alterations in pulmonary structure by elastase administration in a model of emphysema in mice is associated with functional disturbances. Rev Port Pnemol (English Edition). 2012;18(3):128–36.CrossRef
96.
Borzone G, Ramírez B, Reyes T, Moreno R, Lisboa C, González S. Experimental pulmonary emphysema in rats. Inflammatory phenomena and progression of lung damage. Rev Med Chil. 1998;126(10):1153–60.PubMed
97.
Borzone G, Liberona L, Olmos P, Sáez C, Meneses M, Reyes T, et al. Rat and hamster species differences in susceptibility to elastase-induced pulmonary emphysema relate to differences in elastase inhibitory capacity. Am J Physiol Regul Integr Comp Physiol. 2007;293(3):R1342–9.PubMedCrossRef
98.
Vecchiola A, de la Llera JF, Ramírez R, Olmos P, Herrera CI, Borzone G. Differences in acute lung response to elastase instillation in two rodent species may determine differences in severity of emphysema development. Am J Physiol Regul Integr Comp Physiol. 2011;301(1):R148–58.PubMedCrossRef
99.
Marwick JA, Stevenson CS, Giddings J, MacNee W, Butler K, Rahman I, et al. Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition. Am J Physiol Lung Cell Mol Physiol. 2006;290(5):L897–8.PubMedCrossRef
100.
Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000;106(11):1311.PubMedPubMedCentralCrossRef
101.
Taraseviciene-Stewart L, Scerbavicius R, Choe K-H, Moore M, Sullivan A, Nicolls MR, et al. An animal model of autoimmune emphysema. Am J Respir Crit Care Med. 2005;171(7):734–42.PubMedCrossRef
102.
Shapiro SD. Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. Am J Respir Cell Mol Biol. 2000;22(1):4–7.PubMedCrossRef
103.
Shapiro SD. Animal models for COPD. CHEST Journal. 2000;117(5_suppl_1):223S–7S.CrossRef
104.
105.
Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 1997;277(5334):2002–4.PubMedCrossRef
106.
Shapiro SD. The use of transgenic mice for modeling airways disease. Pulm Pharmacol Ther. 2008;21(5):699–1.PubMedCrossRef
107.
Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol. 2003;163(6):2329–35.PubMedPubMedCentralCrossRef
108.
Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese Jr RJ, et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase–and cathepsin-dependent emphysema. J Clin Invest. 2000;106(9):1081.PubMedPubMedCentralCrossRef
109.
Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, Chapman HA, et al. Interferon γ induction of pulmonary emphysema in the adult murine lung. J Exp Med. 2000;192(11):1587–600.PubMedPubMedCentralCrossRef
110.
Cosio M, Ghezzo H, Hogg J, Corbin R, Loveland M, Dosman J, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med. 1978;298(23):1277–81.PubMedCrossRef
111.
Penman RW, O’Neill RP, Begley L. The Progress of Chronic Airway Obstruction in Relation to Measurements of Airway Resistance and Lung Elastic Recoil 1, 2. Am Rev Respir Dis. 1970;101(4):536–44.PubMed
112.
Colebatch H, Finucane K, Smith M. Pulmonary conductance and elastic recoil relationships in asthma and emphysema. J Appl Physiol. 1973;34(2):143–53.PubMed
113.
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd S, on behalf of the GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-76
114.
Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–18.PubMedCrossRef
115.
Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498–4.PubMedCrossRef
116.
Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8(3):183–92.PubMedCrossRef
117.
Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol-Mech. 2009;4:435–59.CrossRef
118.
Duan M-C, Tang H-J, Zhong X-N, Huang Y. Persistence of Th17/Tc17 cell expression upon smoking cessation in mice with cigarette smoke-induced emphysema. Clin Dev Immunol. 2013;2013.
119.
Braber S, Henricks PA, Nijkamp FP, Kraneveld AD, Folkerts G. Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation. Respir Res. 2010;11(1):99.PubMedPubMedCentralCrossRef
120.
Cavarra E, Bartalesi B, Lucattelli M, Fineschi S, Lunghi B, Gambelli F, et al. Effects of cigarette smoke in mice with different levels of α1-proteinase inhibitor and sensitivity to oxidants. Am J Respir Crit Care Med. 2001;164(5):886–90.PubMedCrossRef
121.
Rafiq M, Viswanatha GL, Suryakanth DA, Azeemuddin M, Jagadeesh M, Dhanush K, et al. Poly-Ingredient Formulation Bresol® Ameliorates Experimental Chronic Obstructive Pulmonary Disease (COPD) in Rats. Sci Pharm. 2013;81(3):833.PubMedPubMedCentralCrossRef
122.
James AL, Dirks P, Ohtaka H, Schellenberg R, Hogg JC. Airway responsiveness to intravenous and inhaled acetylcholine in the guinea pig after cigarette smoke exposure. Am J Respir Crit Care Med. 1987;136(5):1158–62.
123.
Dusser D, Djokic T, Borson D, Nadel J. Cigarette smoke induces bronchoconstrictor hyperresponsiveness to substance P and inactivates airway neutral endopeptidase in the guinea pig. Possible role of free radicals. J Clin Invest. 1989;84(3):900.PubMedPubMedCentralCrossRef
124.
Kuo H-P, Lu L-C. Sensory neuropeptides modulate cigarette smoke-induced decrease in neutral endopeptidase activity in guinea pig airways. Life Sci. 1995;57(23):2187–96.PubMedCrossRef
125.
Lee L-Y, Lou Y-P, Hong J-L, Lundberg JM. Cigarette smoke-induced bronchoconstriction and release of tachykinins in guinea pig lungs. Respir physiolo. 1995;99(1):173–81.CrossRef
126.
Hulbert W, McLean T, Hogg J. The Effect of Acute Airway Inflammation on Bronchial Reactivity in Guinea Pigs 1–3. Am Rev Respir Dis. 1985;132(1):7–11.PubMed
127.
Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen G, Irvin C, et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med. 1997;156(3):766–75.PubMedCrossRef
128.
Boskabady MH, Teymoory S. The influence of epithelium on the responsiveness of guinea-pig trachea to ß-adrenergic agonist and antagonist. Med Sci Monit. 2003;9(9):BR336–42.PubMed
129.
Neamati A, Boskabady MH, Afshari JT, Hazrati SM, Rohani AH. The effect of natural adjuvants on tracheal responsiveness and cell count in lung lavage of sensitized guinea pigs. Respirology. 2009;14(6):877–84.PubMedCrossRef
130.
Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(3):822–6.PubMedCrossRef
131.
Saetta M, Di Stefano A, Maestrelli P, Ferraresso A, Drigo R, Potena A, et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis. 1993;147(2):301–6.PubMedCrossRef
132.
Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, Rea F, et al. CD8+ ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(2):711–7.PubMedCrossRef
133.
Vlahos R. Preclinical animal models of COPD. J Inflam. 2013;10 Suppl 1:25.
134.
Cataldo D, Munaut C, Noël A, Frankenne F, Bartsch P, Foidart J-M, et al. MMP-2-and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol. 2000;123(3):259–67.PubMedCrossRef
135.
Vlahos R, Bozinovski S. Recent advances in pre-clinical mouse models of COPD. Clin Sci. 2014;126(4):253–65.PubMedCrossRef
136.
McGrath-Morrow SA, Lauer T, Collaco JM, Yee M, O’Reilly M, Mitzner W, et al. Neonatal Hyperoxia Contributes Additively to Cigarette Smoke??? Induced Chronic Obstructive Pulmonary Disease Changes in Adult Mice. Am J Respir Cell Mol Biol. 2011;45(3):610–6.PubMedPubMedCentralCrossRef
137.
Maryanoff BE, de Garavilla L, Greco MN, Haertlein BJ, Wells GI, Andrade-Gordon P, et al. Dual inhibition of cathepsin G and chymase is effective in animal models of pulmonary inflammation. Am J Respir Crit Care Med. 2010;181(3):247–53.PubMedCrossRef
138.
Chung K. Cytokines in chronic obstructive pulmonary disease. Eur Respir J. 2001;18(34 suppl):50s–9s.CrossRef
139.
Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153(2):530–4.PubMedCrossRef
140.
Barnes P, Shapiro S, Pauwels R. Chronic obstructive pulmonary disease: molecular and cellularmechanisms. Eur Respir J. 2003;22(4):672–88.PubMedCrossRef
141.
Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282(5397):2258–61.PubMedCrossRef
142.
Wright J, Zhou S, Churg A. Pulmonary hypertension and vascular oxidative damage in cigarette smoke exposed eNOS−/− mice and human smokers. Inhal Toxicol. 2012;24(11):732–40.PubMedCrossRef
143.
Wortham BW, Eppert BL, Motz GT, Flury JL, Orozco-Levi M, Hoebe K, et al. NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease. J Immunol. 2012;188(9):4468–75.PubMedPubMedCentralCrossRef
144.
Bergren DR. Tobacco smoke exposure and bombesin-like peptides in guinea pigs. Peptides. 2002;23(5):919–26.PubMedCrossRef
145.
Simani AS, Inoue S, Hogg J. Penetration of the respiratory epithelium of guinea pigs following exposure to cigarette smoke. Laboratory investigation; a journal of technical methods and pathology. 1974;31(1):75.PubMed
146.
Domínguez-Fandos D, Peinado VI, Puig-Pey R, Ferrer E, Musri MM, Ramírez J, et al. Pulmonary inflammatory reaction and structural changes induced by cigarette smoke exposure in the Guinea pig. COPD: Int J Chron Obstruct Pulmon Dis. 2012;9(5):473–84.CrossRef
147.
Wright JL, Zhou S, Preobrazhenska O, Marshall C, Sin DD, Laher I, et al. Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling. Am J Respir Crit Care Med. 2011;183(1):50–8.PubMedCrossRef
148.
Churg A, Marshall CV, Sin DD, Bolton S, Zhou S, Thain K, et al. Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(1):34–3.PubMedCrossRef
149.
Stevens T, Ekholm K, Gränse M, Lindahl M, Kozma V, Jungar C, et al. AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase. J Pharmacol Exp Ther. 2011;339(1):313–20.PubMedCrossRef
150.
Zwicker G, Filipy R, Park J, Loscutoff S, Ragan H, Stevens D. Clinical and pathological effects of cigarette smoke exposure in beagle dogs. Arch Pathol Lab Med. 1978;102(12):623–8.PubMed
151.
King M, Wight A, Desanctis GT, El-Azab J, Phillips DM, Angus GE, et al. Mucus hypersecretion and viscoelasticity changes in cigarette-smoking dogs. Exp Lung Res. 1989;15(3):375–89.PubMedCrossRef
Metadata
Title
Experimental animal models for COPD: a methodological review
Authors
Vahideh Ghorani
Mohammad Hossein Boskabady
Mohammad Reza Khazdair
Majid Kianmeher
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2017
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/s12971-017-0130-2

Other articles of this Issue 1/2017

Tobacco Induced Diseases 1/2017 Go to the issue

Research

Universal electronic-cigarette test: physiochemical characterization of reference e-liquid

Research

Socio-demographic characteristics and tobacco use among the adults in urban slums of Dhaka, Bangladesh

Research

Factors associated with implementation of the 5A’s smoking cessation model

Research

Physicians’ views on the role of smoking in smoking-related diseases: findings from cross-sectional studies from 1982–2014 in Estonia

Research

Practices related to tobacco sale, promotion and protection from tobacco smoke exposure in restaurants and bars in Kampala before implementation of the Uganda tobacco control Act 2015

Research

Characteristics and outcomes of e-cigarette exposure incidents reported to 10 European Poison Centers: a retrospective data analysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits